A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis.

A double blind, crossover study of fibrinolytic enhancement treatment using stanozolol has been performed in primary Raynaud's phenomenon and in systemic sclerosis. The outcome criteria included subjective evaluation, clinical examination, physiological measurements of peripheral blood flow, an...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Jayson, M I, Holland, C D, Keegan, A, Illingworth, K, Taylor, L
Format: Artigo
Jezik:Inglês
Izdano: 1991
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1004323/
https://ncbi.nlm.nih.gov/pubmed/1994867
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki